Literature DB >> 23463376

The motivation to reproject gated blood pool SPECT data as planar data.

Kenneth J Nichols, Denny D Watson.   

Abstract

Mesh:

Year:  2013        PMID: 23463376     DOI: 10.1007/s12350-013-9698-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  14 in total

1.  Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.

Authors:  Azza A G Tantawy; Ola A Elmasry; Magdy Shaaban; Dalia N Toaima; Ali M El Shahat
Journal:  J Pediatr Hematol Oncol       Date:  2011-05       Impact factor: 1.289

2.  Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group.

Authors:  L J Steinherz; T Graham; R Hurwitz; H M Sondheimer; R G Schwartz; E M Shaffer; G Sandor; L Benson; R Williams
Journal:  Pediatrics       Date:  1992-05       Impact factor: 7.124

3.  Left ventricular ejection fraction: comparison of results from planar and SPECT gated blood-pool studies.

Authors:  M L Bartlett; G Srinivasan; W C Barker; A N Kitsiou; V Dilsizian; S L Bacharach
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

4.  Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography.

Authors:  J J Mahmarian; L Moye; M S Verani; T Eaton; M Francis; C M Pratt
Journal:  J Am Coll Cardiol       Date:  1991-07       Impact factor: 24.094

5.  Evaluation of left and right ventricular ejection fraction and volumes from gated blood-pool SPECT in patients with dilated cardiomyopathy: comparison with cardiac MRI.

Authors:  Bo-Qia Xie; Yue-Qin Tian; Jian Zhang; Shi-Hua Zhao; Min-Fu Yang; Feng Guo; Dao-Yu Wang; Hong-Xing Wei; Ke-Wei Chu; Zuo-Xiang He
Journal:  J Nucl Med       Date:  2012-03-05       Impact factor: 10.057

Review 6.  Review of tests for monitoring doxorubicin-induced cardiomyopathy.

Authors:  W I Ganz; K S Sridhar; S S Ganz; R Gonzalez; S Chakko; A Serafini
Journal:  Oncology       Date:  1996 Nov-Dec       Impact factor: 2.935

7.  Reproducibility of equilibrium radionuclide ventriculography in patients with coronary artery disease: response of left ventricular ejection fraction and regional wall motion to supine bicycle exercise.

Authors:  H S Hecht; M A Josephson; J M Hopkins; B N Singh
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

8.  Comparison of interstudy reproducibility of equilibrium electrocardiography-gated SPECT radionuclide angiography versus planar radionuclide angiography for the quantification of global left ventricular function.

Authors:  Doumit Daou; Carlos Coaguila; Abdel Benada
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

9.  Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.

Authors:  Mauro Feola; Ornella Garrone; Marcella Occelli; Antonella Francini; Alberto Biggi; Gianluca Visconti; Fabrizia Albrile; Marco Bobbio; Marco Merlano
Journal:  Int J Cardiol       Date:  2009-11-27       Impact factor: 4.164

10.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

Authors:  S E Lipshultz; S D Colan; R D Gelber; A R Perez-Atayde; S E Sallan; S P Sanders
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

View more
  2 in total

1.  Assessment of an intermediate reprojection technique transitioning from planar to SPECT radionuclide ventriculography.

Authors:  Jim O'Doherty; Bruno Rojas Fisher; Jonathan Mark Price; Kshama Wechalekar
Journal:  J Nucl Cardiol       Date:  2014-08-01       Impact factor: 5.952

2.  Radiation reduction and faster acquisition times with SPECT gated blood pool scans using a high-efficiency cardiac SPECT camera.

Authors:  W Lane Duvall; Krista A Guma-Demers; Titus George; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2015-08-01       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.